Dan is Chief Execution Officer (CXO) with Enveda. He has been with the company since before the seed round, leading Finance, Legal, Quality, SynBio, and Special Projects. With over 10 years of experience in building products and leading companies, he bridges the science, business and operations to make sure Enveda is running as fast as we can reliably and safely. Dan earned his PhD in Molecular Biology and has several publications in high-impact journals. Prior to joining Enveda, Dan, founded and led as CEO a synthetic biology company focused on scalable and cost-effective biologics manufacturing for large pharmaceutical companies, which was later acquired by Vectron Biosolutions.